225 related articles for article (PubMed ID: 25338520)
41. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status.
Maehle BO; Tretli S; Skjaerven R; Thorsen T
Breast Cancer Res Treat; 2001 Jul; 68(2):159-69. PubMed ID: 11688519
[TBL] [Abstract][Full Text] [Related]
42. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
Pahwa R; Adams-Huet B; Jialal I
J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
[TBL] [Abstract][Full Text] [Related]
43. Molecular hydrogen reduces acute exercise-induced inflammatory and oxidative stress status.
Nogueira JE; Passaglia P; Mota CMD; Santos BM; Batalhão ME; Carnio EC; Branco LGS
Free Radic Biol Med; 2018 Dec; 129():186-193. PubMed ID: 30243702
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
45. Trajectories of body mass index across the lifecourse and associations with post-menopausal breast cancer by estrogen receptor status.
Pedersen DC; Aarestrup J; Blond K; Jensen BW; Andersen ZJ; Mellemkjær L; Tjønneland A; Baker JL
Cancer Epidemiol; 2023 Dec; 87():102479. PubMed ID: 37897969
[TBL] [Abstract][Full Text] [Related]
46. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
[TBL] [Abstract][Full Text] [Related]
47. Soymilk supplementation does not alter plasma markers of inflammation and oxidative stress in postmenopausal women.
Beavers KM; Serra MC; Beavers DP; Cooke MB; Willoughby DS
Nutr Res; 2009 Sep; 29(9):616-22. PubMed ID: 19854376
[TBL] [Abstract][Full Text] [Related]
48. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer.
Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; van de Vijver MJ
Eur J Surg Oncol; 1999 Aug; 25(4):356-63. PubMed ID: 10419704
[TBL] [Abstract][Full Text] [Related]
49. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.
Hansen D; Dendale P; Beelen M; Jonkers RA; Mullens A; Corluy L; Meeusen R; van Loon LJ
Eur J Appl Physiol; 2010 Jun; 109(3):397-404. PubMed ID: 20131064
[TBL] [Abstract][Full Text] [Related]
50. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
51. [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status].
Speiser P; Sliutz G; Zeillinger R; Czerwenka K; Jakesz R; Knogler W; Kury F; Reiner A; Sevelda P; Schneeberger C
Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):355-9. PubMed ID: 1634099
[TBL] [Abstract][Full Text] [Related]
52. Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer.
Lubián López DM; Butrón Hinojo CA; Castillo Lara M; Sánchez-Prieto M; Sánchez-Borrego R; Mendoza Ladrón de Guevara N; González Mesa E
Sci Rep; 2021 Jan; 11(1):1872. PubMed ID: 33479372
[TBL] [Abstract][Full Text] [Related]
53. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
54. Association of breast cancer subtypes and body mass index.
Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
[TBL] [Abstract][Full Text] [Related]
55. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.
Mazzarella L; Disalvatore D; Bagnardi V; Rotmensz N; Galbiati D; Caputo S; Curigliano G; Pelicci PG
Eur J Cancer; 2013 Nov; 49(17):3588-97. PubMed ID: 23953055
[TBL] [Abstract][Full Text] [Related]
56. Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.
Accattato F; Greco M; Pullano SA; Carè I; Fiorillo AS; Pujia A; Montalcini T; Foti DP; Brunetti A; Gulletta E
PLoS One; 2017; 12(6):e0178900. PubMed ID: 28582461
[TBL] [Abstract][Full Text] [Related]
57. Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status.
Jiang XP; Yang DC; Elliott RL; Head JF
Cytokine; 2000 May; 12(5):458-65. PubMed ID: 10857759
[TBL] [Abstract][Full Text] [Related]
58. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
[TBL] [Abstract][Full Text] [Related]
59. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.
Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M
Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193
[TBL] [Abstract][Full Text] [Related]
60. [Exploration of the mechanism of xinfeng capsule in the treatment of ankylosing spondylitis based on B and T lymphocyte attenuator and oxidative stress].
Qi YJ; Liu J; Zheng L; Cao YX; Wan L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jan; 35(1):25-32. PubMed ID: 25790670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
